BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37914563)

  • 1. Advancing knowledge-based intensity modulated proton planning for adaptive treatment of high-risk prostate cancer.
    Johnson CL; Hasan S; Huang S; Lin H; Gorovets D; Shim A; Apgar T; Yu F; Tsai P
    Med Dosim; 2024 Spring; 49(1):19-24. PubMed ID: 37914563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
    Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
    J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of integrating knowledge-based planning with multicriteria optimization in treatment planning for prostate SBRT.
    Jayarathna S; Shen X; Chen RC; Li HH; Guida K
    J Appl Clin Med Phys; 2023 Jun; 24(6):e13940. PubMed ID: 36827178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
    Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
    Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical iterative model development improves knowledge-based plan quality for high-risk prostate cancer with four integrated dose levels.
    Hundvin JA; Fjellanger K; Pettersen HES; Nygaard B; Revheim K; Sulen TH; Ekanger C; Hysing LB
    Acta Oncol; 2021 Feb; 60(2):237-244. PubMed ID: 33030972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
    Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M
    Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it possible for knowledge-based planning to improve intensity modulated radiation therapy plan quality for planners with different planning experiences in left-sided breast cancer patients?
    Wang J; Hu W; Yang Z; Chen X; Wu Z; Yu X; Guo X; Lu S; Li K; Yu G
    Radiat Oncol; 2017 May; 12(1):85. PubMed ID: 28532508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric advantages of daily adaptive strategy in IMPT for high-risk prostate cancer.
    Tamura H; Kobashi K; Nishioka K; Yoshimura T; Hashimoto T; Shimizu S; Ito YM; Maeda Y; Sasaki M; Yamamoto K; Tamamura H; Aoyama H; Shirato H
    J Appl Clin Med Phys; 2022 Apr; 23(4):e13531. PubMed ID: 35045211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validation and benchmarking of knowledge-based IMRT and VMAT treatment planning in pelvic anatomy.
    Hussein M; South CP; Barry MA; Adams EJ; Jordan TJ; Stewart AJ; Nisbet A
    Radiother Oncol; 2016 Sep; 120(3):473-479. PubMed ID: 27427380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning-based automatic proton therapy planning: Impact of post-processing and dose-mimicking in plan robustness.
    Borderias-Villarroel E; Huet Dastarac M; Barragán-Montero AM; Helander R; Holmstrom M; Geets X; Sterpin E
    Med Phys; 2023 Jul; 50(7):4480-4490. PubMed ID: 37029632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
    Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
    J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.
    Yeo I; Nookala P; Gordon I; Schulte R; Barnes S; Ghebremedhin A; Wang N; Yang G; Ling T; Bush D; Slater J; Patyal B
    Radiat Oncol; 2015 Oct; 10():213. PubMed ID: 26499318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an Automated Proton Planning Solution.
    Delaney AR; Verbakel WF; Lindberg J; Koponen TK; Slotman BJ; Dahele M
    Cureus; 2018 Dec; 10(12):e3696. PubMed ID: 30788187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatic IMRT planning via static field fluence prediction (AIP-SFFP): a deep learning algorithm for real-time prostate treatment planning.
    Li X; Zhang J; Sheng Y; Chang Y; Yin FF; Ge Y; Wu QJ; Wang C
    Phys Med Biol; 2020 Sep; 65(17):175014. PubMed ID: 32663813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
    Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy.
    Zhang P; Fan N; Shan J; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2017 Sep; 18(5):29-35. PubMed ID: 28681976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.